Healthcare Access

Trump's Most Favored Nation drug pricing policy is already delaying new medicine launches in Europe. Brussels journalist Christoffer Frendesen unpacks the silence, the data, and why it may outlast the Trump presidency. #SyenzaNews #MarketAccess #DrugPricing

US Medicare is paying for obesity GLP-1s for the first time, and more than 500,000 seniors signed up in the first two months. Our latest breaks down the $245 price, the $50 copay, and what it means for Lilly and Novo Nordisk. #SyenzaNews #MarketAccess #GLP1 #Medicare

💊 Can generic medicines deliver €300 million in savings for Portugal? Portugal is targeting major cost reductions in its healthcare system by accelerating the uptake of generic medicines, aiming to improve affordability and sustainability. This move highlights strategic efforts in market access and cost-effectiveness within the pharmaceutical sector. Read the full analysis to see what it means for stakeholders. #SyenzaNews #pharmaceuticals #MarketAccess #costeffectiveness

The NICE Decision Support Unit and EEPRU have released updated Stata, Excel and R commands for mapping EQ-5D-3L data to the new EQ-5D-5L value set, giving UK HTA analysts a validated route to convert legacy three-level utility data ahead of NICE's adoption of the five-level value set.

How are cell therapies redefining cancer care through rigorous HTA evaluation? INCA’s latest analysis highlights how CAR-T and other advanced cell therapies are shifting oncology paradigms—balancing innovation with evidence-based access and cost-effectiveness. Explore the full breakdown and its implications for global cancer treatment. #SyenzaNews #oncology #precisionmedicine #innovation #MarketAccess

Can local procurement policies turn the tide for South Africa’s pharmaceutical jobs? A strategic shift toward prioritizing local pharma manufacturing could safeguard thousands of positions while strengthening supply chain resilience and economic growth. This approach balances cost considerations with long-term industrial development in the sector. Explore the full analysis. #SyenzaNews #pharmaceuticals #MarketAccess #healthcarepolicy

How is South Africa advancing local production of cutting-edge HIV treatments? The country has shortlisted manufacturers for Lenacapavir, paving the way for greater domestic capacity, improved access, and stronger pharmaceutical supply chains across the region. Explore how this step supports broader drug development goals. #SyenzaNews #pharmaceuticals #drugdevelopment #innovation #MarketAccess

How is Portugal expanding access to advanced prostate cancer therapies? The country has approved reimbursement for the niraparib-abiraterone combination, strengthening patient options in oncology and highlighting progress in pharmaceutical market access. Discover what this means for treatment innovation and healthcare policy. #SyenzaNews #oncology #MarketAccess

Is Africa's HIV future at a crossroads? The Africa HIV Control Working Group's 2026 webinar spotlighted UNAIDS, UNICEF & health leaders on domestic financing, sovereignty, integrated systems & community leadership to build resilient HIV control. Read more & join the push for bold action. #HIVControl #AfricaHealth #BoldLeadership #UNAIDS #GlobalHealth

🧪 Could a blood-based test be the breakthrough Africa needs to turn the tide on TB? A new diagnostic approach is significantly improving case detection rates, enabling earlier intervention in high-burden regions. Discover how this innovation is reshaping tuberculosis control strategies. #SyenzaNews #globalhealth #biotechnology #innovation

How is Greater Manchester leading the way in integrated health policy? Devolution has enabled closer collaboration across NHS, local government, and social care, driving more coordinated policy outcomes and improved population health. Explore the latest insights on this evolving model. #SyenzaNews #healthcare #HealthcareInnovation #governance #healthcarepolicy

🌍 How is Africa strengthening its vaccine independence? Recent expansions are significantly boosting Biovac’s manufacturing capacity, enabling greater local production and reducing reliance on imports. This marks a key step toward sustainable vaccine supply across the continent. Read the full story. #SyenzaNews #biotechnology #globalhealth #innovation